Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKALL60+ Study for Older Adults with ALL
NCT01616238Phase 2Completed
- Sponsor
- University College London
- Start
- Dec 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by University College London. Started Dec 2012; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01616238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616238.